Day One Biopharmaceuticals, Inc.DAWNNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+25.7%
5Y CAGR+92.8%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+25.7%/yr
Annual compound
5Y CAGR
+92.8%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
26.6x
Strong expansion
Streak
6 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $120.59M | +4.4% |
| 2024 | $115.45M | +53.6% |
| 2023 | $75.16M | +23.7% |
| 2022 | $60.76M | +109.8% |
| 2021 | $28.96M | +539.7% |
| 2020 | $4.53M | +350.0% |
| 2019 | $1.01M | - |